KUMAR, Shankar,TSURUSHITA, Naoya,AHLIJANIAN, Michael,JEFSON, Martin
申请号：
AU2018364630
公开号：
AU2018364630A1
申请日:
2018.11.08
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present disclosure relates generally to conformation-specific antibodies that can bind to and neutralize the activity of phosphorylated-Threonine 231-tau protein (pT231-tau). The antibodies of the present technology are useful in methods for treating a neurological disorder associated with elevated cis-pT231-tau protein expression in a subject in need thereof.
